Dr. Chrysoula Boutari, MSc, PhD, MD, graduated from the Medical School of the Aristotle University of Thessaloniki, Greece in 2011. She obtained her PhD with Honors from the same University in 2017. She is a specialist in Internal Medicine and her PhD was based on the effect of rosuvastatin on patients with nonalcoholic fatty liver disease. She is currently a Registrar at the Ippokratio University Hospital, Thessaloniki, Greece. Dr. Boutari was an Honorary Clinical Research Fellow at the Department of Endocrinology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, USA, participating in the department's clinical and research activities, funded by grants from the World Hellenic Biomedical Association and the Stavros Niarchos Foundation for Charity. She is currently a member of the Executive Board of the Hellenic Atherosclerosis Society (HAS). Dr. Boutari’s clinical and research interests involve cardiometabolic diseases, including dyslipidemia, non-alcoholic fatty liver disease, obesity, dyslipidemia, and diabetes prevention and treatment.